These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 9533847

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Quantitation of galactosemic cataracts in dogs using magnetization transfer contrast-enhanced magnetic resonance imaging.
    Lizak MJ, Mori K, Ceckler TL, Balaban RS, Kador PF.
    Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2219-27. PubMed ID: 8843908
    [Abstract] [Full Text] [Related]

  • 25. Inhibition of galactose-induced alterations in ocular lens with sorbinil.
    Unakar NJ, Tsui JY.
    Exp Eye Res; 1983 May; 36(5):685-94. PubMed ID: 6303825
    [Abstract] [Full Text] [Related]

  • 26. Medical therapy in the prevention of cataract.
    Brown NA, Bron AJ.
    Trans Ophthalmol Soc U K (1962); 1985 May; 104 ( Pt 7)():748-54. PubMed ID: 3938085
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Effects of M79175, an aldose reductase inhibitor, on experimental sugar cataracts].
    Ono H, Nozawa Y, Hayano S.
    Nippon Ganka Gakkai Zasshi; 1982 May; 86(9):1343-50. PubMed ID: 6818854
    [No Abstract] [Full Text] [Related]

  • 30. [The inhibitory effect of aldose reductase inhibitor for proliferation in the lens epithelial cells of rat sugar cataract].
    Morikubo S, Takamura Y, Kubo E, Tsuzuki S, Akagi Y.
    Nippon Ganka Gakkai Zasshi; 2003 Oct; 107(10):565-70. PubMed ID: 14598706
    [Abstract] [Full Text] [Related]

  • 31. Prefeeding of aldose reductase inhibitor and galactose cataractogenesis.
    Unakar NJ, Tsui JY, Johnson MJ.
    Curr Eye Res; 1989 Oct; 8(10):997-1010. PubMed ID: 2558845
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Effects of aldose reductase inhibitor (M79175) on ERG oscillatory potential abnormalities in streptozotocin fructose-induced diabetes in rats.
    Funada M, Okamoto I, Fujinaga Y, Yamana T.
    Jpn J Ophthalmol; 1987 Oct; 31(2):305-14. PubMed ID: 3118085
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Iris vasculopathy in galactose-fed rats.
    Caspers-Velu LE, Wadhwani KC, Rapoport SI, Kador PF.
    Exp Eye Res; 1999 Feb; 68(2):211-21. PubMed ID: 10068486
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Polyol formation and NADPH-dependent reductases in dog retinal capillary pericytes and endothelial cells.
    Sato S, Secchi EF, Lizak MJ, Fukase S, Ohta N, Murata M, Tsai JY, Kador PF.
    Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):697-704. PubMed ID: 10067973
    [Abstract] [Full Text] [Related]

  • 38. In utero and milk-mediated effect of aldose reductase inhibitor on galactose cataracts.
    Unakar NJ, Tsui JY, Johnson M, Dang L.
    Exp Eye Res; 1991 Nov; 53(5):665-76. PubMed ID: 1743265
    [Abstract] [Full Text] [Related]

  • 39. Reversal of galactose cataract with Sorbinil in rats.
    Hu TS, Datiles M, Kinoshita JH.
    Invest Ophthalmol Vis Sci; 1983 May; 24(5):640-4. PubMed ID: 6841013
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.